Beam Therapeutics BEAM Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's short- and long-term operating lease liabilities?
- Beam Therapeutics (BEAM) reported short- and long-term operating lease liabilities of -$3.49M in Q1 2026.
- How has Beam Therapeutics's short- and long-term operating lease liabilities changed year-over-year?
- Beam Therapeutics's short- and long-term operating lease liabilities decreased by 6.0% year-over-year, from -$3.3M to -$3.49M.
- What is the long-term trend for Beam Therapeutics's short- and long-term operating lease liabilities?
- Over 4 years (2021 to 2025), Beam Therapeutics's short- and long-term operating lease liabilities has grown at a -4.2% compound annual growth rate (CAGR), from $16.03M to -$13.51M.